Minoxidil can grow eyebrow hair. Multiple randomized controlled trials have found that topical minoxidil, usually at 2% concentration applied twice daily, produces measurably thicker and more numerous eyebrow hairs compared to placebo over about 16 weeks. It is not FDA-approved for this purpose, so every prescription or recommendation for eyebrows is off-label, but the evidence behind it is stronger than for many other off-label hair-loss treatments.
What the Trials Actually Show
The most frequently cited trial on this topic is a randomized, double-blind, placebo-controlled study using a split-face design, meaning each participant applied minoxidil 2% to one eyebrow and placebo to the other. After 16 weeks, the minoxidil side showed significantly better results in hair count, hair diameter, and patient self-assessment, with only minor side effects.1PubMed. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study A systematic review and meta-analysis confirmed these findings, reporting that minoxidil increased hair diameter by roughly 3.6 micrometers more than placebo at 16 weeks and that both 2% and 3% concentrations outperformed placebo across different trials on measures including hair count and photographic assessment.2PubMed Central. Topical minoxidil effectiveness in enhancing facial aesthetics: A systematic review and meta-analysis
A separate randomized trial compared topical minoxidil 2% head-to-head with two concentrations of bimatoprost (a prostaglandin analog sometimes used for eyelash growth). All three treatment arms produced statistically significant improvements in a standardized eyebrow assessment scale, hair count, and hair diameter after 16 weeks. The minoxidil group gained an average of about five additional hairs per measured area and nearly four micrometers in hair diameter. There was no statistically significant difference between the minoxidil and bimatoprost groups on the overall assessment score.3PubMed Central. Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial
How Minoxidil Encourages Eyebrow Growth
Minoxidil was originally developed as a blood-pressure medication, and its hair-growing effects were discovered as an unintended side effect. The drug works by shortening the resting phase of the hair cycle and pushing dormant follicles into the active growth phase sooner than they would enter it on their own. Animal studies confirm this, and the same mechanism likely operates in humans. On top of that, minoxidil stimulates cell proliferation within the follicle and increases production of vascular endothelial growth factor, which improves blood flow to the follicle base.4PubMed. Minoxidil: mechanisms of action on hair growth Lab work has also shown that minoxidil activates key growth-signaling pathways in the cells of both the hair bulge and the dermal papilla, the structures responsible for generating new hair.5PubMed. Human platelet lysate versus minoxidil stimulates hair growth by activating anagen promoting signaling pathways
This matters for eyebrows specifically because eyebrow hairs have a shorter growth cycle than scalp hairs. Their active growth phase lasts only a few months rather than several years, which is why eyebrow hairs stay short. Minoxidil does not change the fundamental length limit of eyebrow hair, but it can coax more follicles into that active growth window at the same time, making the brow look denser and fuller.
Practical Use and Timeline
Most trials used 2% minoxidil solution applied twice a day with a small applicator or cotton swab. You apply a thin layer to the sparse area and let it dry. The 2% concentration is the one with the most published eyebrow-specific data, and it appears to work well enough that jumping to 5% is hard to justify for most people, particularly given the proximity to the eyes. Some trials have also tested 1% and 3% concentrations successfully, but 2% is the most commonly studied.6PubMed Central. Topical minoxidil effectiveness in enhancing facial aesthetics: A systematic review and meta-analysis
Patience is non-negotiable. The trials typically run 16 weeks before measuring outcomes, and many dermatologists recommend waiting at least that long before judging whether it is working. Some people see early fuzz within a few weeks, but meaningful cosmetic improvement tends to take three to four months. This timeline is consistent with the drug’s mechanism: it takes time for resting follicles to re-enter the growth phase and produce visible hair.
An important caveat: once you stop applying minoxidil, the new growth gradually reverts. The drug does not permanently reprogram follicles. If the underlying cause of eyebrow thinning is still present, the hairs that grew during treatment will eventually shed once the stimulus is removed. Some people use minoxidil for a defined period and then switch to a lower maintenance frequency, but there is little formal data on the best tapering schedule for eyebrows specifically.
Why It Works Better for Some People Than Others
One of the frustrating things about minoxidil is that response rates vary widely. Scalp research has identified a key reason: minoxidil itself is actually a prodrug, meaning it needs to be converted into its active form (minoxidil sulfate) by an enzyme called sulfotransferase. The amount of this enzyme in your hair follicles varies from person to person, and that variation directly affects how well the drug works for you.7PubMed Central. Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
One study on oral minoxidil found that patients with lower follicular enzyme activity actually had a higher response rate (about 85%) compared to those with higher enzyme activity (about 43%), a somewhat counterintuitive finding that researchers are still working to explain.8PubMed. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia The relationship between enzyme levels and treatment success is clearly real but not fully understood, and virtually all of this research has been done on scalp hair, not eyebrows. Still, dermatologists sometimes use these findings to explain why one patient sees dramatic eyebrow regrowth while another sees very little after the same treatment period.
It is also worth noting that eyebrow hair varies in density, diameter, and growth direction depending on its position within the brow. The inner part near the nose, the arch, and the tail all behave slightly differently.9PubMed. Eyebrow growth pattern analysis in patients with eyebrow hypotrichosis after receiving topical treatment: A retrospective study This means a single application strategy may not work equally well across the entire brow, and some areas may respond faster or more fully than others.
Side Effects and Safety Concerns Near the Eyes
The biggest practical concern with eyebrow application is the proximity to the eyes. Minoxidil is a vasodilator, and applying it close to ocular tissue raises questions that do not come up when you are putting it on your scalp.
In clinical trials on eyebrows specifically, side effects have been mild. The head-to-head trial comparing minoxidil 2% with bimatoprost recorded just one case of contact dermatitis in the minoxidil group and no other adverse events of significance.10PubMed Central. Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial The split-face placebo-controlled trial likewise reported that side effects were minor and did not cause anyone to drop out.11PubMed. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study
That said, a structured review of ocular events linked to minoxidil use (primarily from scalp application) found a rare but real spectrum of eye-related problems. The most commonly reported was a condition called central serous chorioretinopathy, accounting for about 58% of cases in the review, followed by retinal vascular occlusion. About three-quarters of these cases involved topical minoxidil rather than oral forms. The review’s authors recommended that clinicians counsel patients to report any new visual symptoms.12PubMed. Ocular Events Temporally Associated With Minoxidil: A Structured Review These events remain rare, but they are worth knowing about when you are deliberately applying the drug beside your eyes. If you notice vision changes, blurriness, or eye discomfort after starting eyebrow minoxidil, talk to a doctor rather than waiting it out.
Unwanted Hair Growth Elsewhere on the Face
Hypertrichosis, meaning new hair growth in places you did not intend, is the most commonly discussed cosmetic side effect. When minoxidil is used on the scalp, the drug can migrate via contact transfer to the forehead or cheeks, causing fine vellus hair to appear. In clinical trials involving over 1,300 women using topical minoxidil on the scalp, about 4% spontaneously reported hypertrichosis or facial hair growth. The effect followed a dose-related pattern: 5% minoxidil produced more cases than 2%, which produced more than placebo. Post-marketing surveillance data suggested a lower real-world rate of about 0.5%.13PubMed. Hypertrichosis in females applying minoxidil topical solution and in normal controls
When applying minoxidil directly to the brow area, there is some logic in assuming the risk of localized facial hypertrichosis could be higher, since you are putting the drug directly on the face rather than just occasionally transferring traces. A case-series review noted that the unwanted hair is often fine vellus hair, and that women over 50, women with pre-existing facial hair, and those of Mediterranean, Hispanic, or Middle Eastern descent appear to be at somewhat higher risk.14Actas Dermo-Sifiliográficas. Generalized Hypertrichosis Due to Topical Minoxidil In practice, careful application with a small brush or cotton-tip applicator, avoiding dripping, and washing your hands after application can reduce spread to unwanted areas.
Oral Minoxidil for Eyebrows
Low-dose oral minoxidil has gained traction in dermatology over the past several years, mainly for scalp hair loss that does not respond well to topical formulations. There is a small amount of evidence for its effect on eyebrows, mostly from studies focused on frontal fibrosing alopecia, a scarring condition that often destroys eyebrow follicles. In one prospective study of patients with this condition, four out of eight patients evaluated for eyebrow response showed improvement after oral minoxidil treatment. Five of the ten study completers experienced mild hypertrichosis as a side effect.15PubMed Central. Low-Dose Oral Minoxidil Improves Hairline and Eyebrow Coverage in Frontal Fibrosing Alopecia: A Prospective Study
Oral minoxidil is a prescription medication with systemic effects, including potential drops in blood pressure, fluid retention, and body-wide hypertrichosis. For someone whose only goal is fuller eyebrows, the risk-benefit calculation is very different from someone battling widespread scarring alopecia. Most dermatologists would start with topical application for cosmetic eyebrow enhancement and consider oral minoxidil only if the underlying condition demands it.
Combining Minoxidil with Microneedling
In scalp hair loss, pairing minoxidil with microneedling has shown promise. The tiny punctures created by a dermaroller or dermapen increase drug absorption and trigger a wound-healing response that may independently stimulate follicle activity. A systematic review noted that microneedling combined with 5% minoxidil increased hair count more than either minoxidil alone, laser therapy alone, or microneedling alone.16PubMed Central. Topical minoxidil effectiveness in enhancing facial aesthetics: A systematic review and meta-analysis
Whether this combination translates equally to eyebrows is less clear. The eyebrow area has thinner skin and sits close to the eyes, so aggressive microneedling carries more risk than it does on the scalp. Some practitioners use very shallow needle depths on the brow, but formal eyebrow-specific data on the combination is limited. If you are considering this approach, it is worth doing it under professional guidance rather than going at your brow with a consumer dermaroller and hoping for the best.
Minoxidil vs. Bimatoprost for Eyebrows
Bimatoprost is the active ingredient in Latisse, the FDA-approved product for eyelash hypotrichosis. Because it works through a completely different mechanism (prostaglandin pathway rather than vasodilation), it gets compared to minoxidil frequently. The randomized trial described earlier found no statistically significant difference between minoxidil 2% and bimatoprost at either 0.01% or 0.03% concentrations on the overall eyebrow assessment score at 16 weeks.17PubMed Central. Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial Both treatments work, and both take a similar amount of time.
There are practical differences, though. Bimatoprost can cause periorbital skin darkening and iris color changes (darkening of the iris) with prolonged use, side effects that minoxidil does not share. On the other hand, bimatoprost has more regulatory precedent near the eyes given its FDA approval for lashes. Minoxidil is cheaper and available over the counter in its topical form, which makes it more accessible. For many people, the decision comes down to cost, convenience, and which side-effect profile they are more comfortable with.
The Off-Label Question
Minoxidil is FDA-approved only for androgenetic alopecia on the scalp. Every other use, including eyebrows, is off-label. A comprehensive review of off-label topical minoxidil applications found that while the evidence is mixed for some conditions like scarring alopecia, the evidence for eyebrow hypotrichosis is among the more supportive categories in the off-label literature.18PubMed. Off-Label Use of Topical Minoxidil in Alopecia: A Review This means dermatologists who recommend it for eyebrows are not acting on a hunch but on a real, if limited, evidence base.
Still, off-label status means the product packaging will not include instructions for eyebrow use. You will not find concentration recommendations, application tips, or eyebrow-specific safety data in the box. If you are buying minoxidil over the counter for your brows, you are essentially your own pharmacist, which is another reason it helps to involve a dermatologist who has experience with this application.
When Thin Eyebrows Signal Something Else
Before reaching for a bottle of minoxidil, it is worth considering why your eyebrows are thin in the first place. Eyebrow loss can be purely cosmetic or age-related, but it can also be a clinical sign of something more systemic. The term for eyebrow and eyelash loss is madarosis, and the list of potential causes is long.19PubMed Central. Madarosis: a marker of many maladies
Nonscarring causes include autoimmune conditions like alopecia areata, endocrine disorders such as hypothyroidism, infections, nutritional deficiencies, inflammatory skin conditions like atopic dermatitis, and medication side effects.20Journal of Drugs in Dermatology. Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I – Nonscarring Disorders Scarring causes, which destroy the follicle permanently, include frontal fibrosing alopecia and certain infections. In scarring conditions, topical minoxidil is unlikely to regrow hair because the follicle itself has been replaced by scar tissue. Some cases are idiopathic, meaning no underlying cause is ever found.21PubMed. Acquired causes of eyebrow and eyelash loss: A review and approach to diagnosis and treatment
This distinction matters practically. If your eyebrows are thinning because of hypothyroidism, the correct first step is to treat the thyroid problem, not to paper over the symptom with minoxidil. If the cause is alopecia areata, minoxidil might help as part of a broader strategy, but immunological treatments often take priority. And if the cause is a scarring process, minoxidil alone will not bring back what is already gone, though it may help preserve what remains.
The Emotional Weight of Eyebrow Loss
Eyebrows do a surprising amount of social and emotional heavy lifting. They frame the face, convey expression, and contribute to how others read your mood. Losing them, even partially, can affect self-image in ways that feel disproportionate to the amount of actual tissue involved. Research on patients with eyebrow and eyelash loss has documented a real impact on quality of life, encompassing both the functional role of brows (keeping sweat and debris out of the eyes) and the psychological toll of a changed appearance.22PubMed Central. Impact and Management of Loss of Eyebrows and Eyelashes
This context helps explain why a treatment as unexciting as applying a topical solution twice a day for four months can feel genuinely life-changing for some people. It also explains why the cosmetics industry has invested so heavily in brow products like microblading, tinting, and pencils. Minoxidil occupies an unusual middle ground: it is a pharmaceutical intervention for something many people and some physicians dismiss as “just cosmetic.” But the psychological evidence suggests the stakes are higher than that framing implies, and treating eyebrow thinning as a legitimate concern rather than vanity is increasingly the norm in dermatology.

